Viewing StudyNCT00050141



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00050141
Status: COMPLETED
Last Update Posted: 2013-02-01
First Post: 2002-11-22

Brief Title: Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Anti-estrogen therapy View
Breast cancer View
ZARNESTRA View
tipifarnib View
R115777 View
Estrogen receptor positive View
Progesterone receptor positive View